Could FAP-Targeted Molecular Imaging Replace ¹⁸F-FDG for Standard-of-Care Oncologic PET?

J Nucl Med. 2023 Apr;64(4):623-624. doi: 10.2967/jnumed.122.265003. Epub 2023 Feb 2.

Authors

Raghava Kashyap¹, Aravind S Ravi Kumar^{2

3}

Affiliations

¹ Department of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; and.
² Department of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; and aravind.ravikumar@petermac.org.
³ Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.

PMID: 36732058
DOI: 10.2967/jnumed.122.265003

No abstract available

Publication types

Comment

MeSH terms

Endopeptidases / metabolism
Fluorodeoxyglucose F18*
Medical Oncology
Membrane Proteins / metabolism
Molecular Imaging
Positron Emission Tomography Computed Tomography / methods
Positron-Emission Tomography* / methods
Radiopharmaceuticals

Substances

Fluorodeoxyglucose F18
Radiopharmaceuticals
Endopeptidases
Membrane Proteins